Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Asset / Drug

University

Drug and asset intelligence for University with 8 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
8
Catalysts
0
Stage
Development stage unavailable

Recent signals(8)

ClinicalAugust 15, 2026

University of Arkansas initiates PTSD therapy study for pregnant women in substance use care

The University of Arkansas is conducting a study to assess the feasibility and acceptability of Written Exposure Therapy via tele-health for pregnant and postpartum individuals with PTSD in substance misuse settings.

ClinicalAugust 13, 2026

University of Alabama at Birmingham Initiates Longitudinal Study on [18F]DPA-714 in Parkinson's Disease

[18F]DPA-714 PET imaging study initiated to assess binding in prodromal and early Parkinson's Disease over 24 months.

ClinicalJuly 20, 2026

University of Rochester Launches eGAP Study for Older Cancer Patients

The University of Rochester is conducting a feasibility study on the electronic Geriatric Assessment Platform (eGAP) involving 50 older cancer patients.

ClinicalJuly 20, 2026

University of Missouri-Columbia Launches Naloxone Training Initiative to Combat Opioid Overdoses

The Opioid Rapid Response System (ORRS) project aims to train citizens in naloxone administration to reduce opioid overdose deaths.

ClinicalJuly 16, 2026

University of Missouri Initiates Study on Lymphatic Pain and Lymphedema Management

A new clinical trial aims to implement digital assessments and self-care interventions for lymphatic pain and lymphedema in breast cancer patients.

ClinicalJuly 1, 2026

University of Florida Tests PINPOINT Intervention for Cervical Cancer Prevention

The University of Florida is adapting and testing the PINPOINT intervention to improve cervical cancer prevention among high-risk patients.

ClinicalJune 28, 2026

University of Bern Trials Remote Cognitive Training for Alzheimer's Disease

A study is underway to assess the feasibility and usability of a tablet-based cognitive training program for Alzheimer's disease.

ClinicalJune 22, 2026

University of Edinburgh Investigates Innate Immunity Mechanisms in COPD

The study aims to understand the metabolic dysfunction of immune cells in COPD patients and its impact on bacterial clearance.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

Alzheimer's Disease →
Cervical Cancer →
Chronic Obstructive Pulmonary Disease (COPD) →
Parkinson's Disease →

Therapeutic areas

Addiction →
Alzheimer's Disease →
Cervical Cancer →
Chronic Obstructive Pulmonary Disease (COPD) →
Geriatric Assessment →
Lymphedema →
Mental Health →
Neurology →
Oncology →
Opioids →
Parkinson's Disease →
PTSD →
Respiratory →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.